VaramirStart free · no cardSign in
SLS as of Oct 31 · 05:31 ET
SLSNasdaqPharmaceutical Preparations

SELLAS Life Sciences Group, Inc. · Brief

Next report

11 days

Nov 11 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±10.4%
avg realized
±7.3%
Mar 20 '25±13.2%▼−0.83%×0.06
May 13 '25±13.0%▲+7.09%×0.55
Aug 12 '25±11.0%▼−3.73%×0.34
Q3 FY25±13.7%▼−2.01%×0.15
Jan 8 '26±9.6%▼−4.46%×0.47
Q1 FY26±5.8%▼−8.46%×1.46
May 12 '26±7.9%▲+25.10%×3.19
Q2 FY26±9.4%▲+6.52%×0.70
quarterimplied−30%0+30%realized×
Q2 FY26±9.4%▲+6.52%×0.70
May '26±7.9%▲+25.10%×3.19
Q1 FY26±5.8%▼−8.46%×1.46
Jan '26±9.6%▼−4.46%×0.47
Q3 FY25±13.7%▼−2.01%×0.15
Aug '25±11.0%▼−3.73%×0.34
2 older reports
May '25±13.0%▲+7.09%×0.55
Mar '25±13.2%▼−0.83%×0.06
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2 of 4

+35.86%largest reporting managers increased their aggregate shares during the latest quarter13F · Jun 30 '26
208managers reporting positions in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

6 of 8recent reports where moves came in under the options implied rangeEarnings history
1.19%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

SLS report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 28impliedImplied move: ±29.9% into Nov 11 earnings (Oct 28 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.